181 related articles for article (PubMed ID: 30275227)
21. Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
Ishigami H; Fujiwara Y; Fukushima R; Nashimoto A; Yabusaki H; Imano M; Imamoto H; Kodera Y; Uenosono Y; Amagai K; Kadowaki S; Miwa H; Yamaguchi H; Yamaguchi T; Miyaji T; Kitayama J
J Clin Oncol; 2018 Jul; 36(19):1922-1929. PubMed ID: 29746229
[TBL] [Abstract][Full Text] [Related]
22. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
23. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.
Imano M; Peng YF; Itoh T; Nishikawa M; Satou T; Yasuda A; Inoue K; Kato H; Shinkai M; Tsubaki M; Yasuda T; Imamoto H; Nishida S; Furukawa H; Takeyama Y; Okuno K; Shiozaki H
Anticancer Res; 2012 Sep; 32(9):4071-5. PubMed ID: 22993363
[TBL] [Abstract][Full Text] [Related]
24. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
[TBL] [Abstract][Full Text] [Related]
25. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
26. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
[TBL] [Abstract][Full Text] [Related]
27. [A case of gastric cancer with peritoneal dissemination which showed the intraperitoneal CR by administrating TS-1 orally and paclitaxel intraperitoneally].
Miki H; Tamura S; Wada H; Kozuma Y; Kittaka N; Kim T; Takiuchi D; Aihara T; Sugimoto K; Fukunaga M; Ozato H; Tomita N; Takatsuka Y
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1661-4. PubMed ID: 14619488
[TBL] [Abstract][Full Text] [Related]
28. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
Kobayashi M; Tsuburaya A; Nagata N; Miyashita Y; Oba K; Sakamoto J
Gastric Cancer; 2006; 9(2):114-9. PubMed ID: 16767367
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
30. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
[TBL] [Abstract][Full Text] [Related]
31. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer.
Kim JY; Do YR; Park KU; Kim JG; Chae YS; Kim MK; Lee KH; Ryoo HM; Bae SH; Baek JH; Song HS
Cancer Chemother Pharmacol; 2011 Mar; 67(3):527-32. PubMed ID: 20461377
[TBL] [Abstract][Full Text] [Related]
32. [A case of gastric cancer with peritoneal dissemination who achieved long survival by successive treatments with S-1 in combination with CDDP, paclitaxel and irinotecan].
Seshimo K; Kanagawa T; Yamashita Y; Oishi M; Kodera M; Yamamura M; Katoh H; Ikeda H; Yokomichi N; Kobayashi K; Takita K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1741-4. PubMed ID: 19838039
[TBL] [Abstract][Full Text] [Related]
33. [An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
Kadono M; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2442-4. PubMed ID: 21224600
[TBL] [Abstract][Full Text] [Related]
34. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
Takahari D; Hamaguchi T; Yoshimura K; Katai H; Ito S; Fuse N; Konishi M; Yasui H; Terashima M; Goto M; Tanigawa N; Shirao K; Sano T; Sasako M
Gastric Cancer; 2014 Apr; 17(2):383-6. PubMed ID: 23719867
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer.
Satoh S; Okabe H; Teramukai S; Hasegawa S; Ozaki N; Ueda S; Tsuji A; Sakabayashi S; Fukushima M; Sakai Y
Gastric Cancer; 2012 Jan; 15(1):61-9. PubMed ID: 21667134
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer.
Tamura S; Miki H; Okada K; Takeno A; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gastric Cancer; 2010 Jun; 13(2):101-8. PubMed ID: 20602197
[TBL] [Abstract][Full Text] [Related]
38. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
39. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
[TBL] [Abstract][Full Text] [Related]
40. Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer.
Kurokawa Y; Hamakawa T; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Anticancer Res; 2015 Apr; 35(4):2223-8. PubMed ID: 25862882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]